 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
Plaintiffs Challenging Myriad's Aussie BRCA Patent Will Appeal Federal Court's Dismissal of Case
February 20, 2013
Plaintiffs Challenging Myriad's Aussie BRCA Patent Will Appeal Federal Court's Dismissal of Case
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Australian Patient Groups Follow ACLU/PUBPAT Path in Challenging Gene Patenting
June 16, 2010 / Pharmacogenomics Reporter - SCOTUS Justices Struggle to Draw Line between Isolated DNA, cDNA in Gene Patent Hearing
April 17, 2013 / Pharmacogenomics Reporter - Myriad Prepared to Make Small IP Sacrifice to Aussies in Light of Landmark US Patent Case
October 6, 2010 / Pharmacogenomics Reporter - Narrow Ruling in Bilski Is a Win for Dx Developers, Despite Ambiguity on Gene-Patent Questions
June 30, 2010 / Pharmacogenomics Reporter - GenomeWeb Feature: Regardless of Gene Patent Challenges, Myriad Faces Shifting Competitive Landscape
April 17, 2013 / Pharmacogenomics Reporter